SCHEMBL4295300

SCHEMBL4295300

COc1cc(C)c(S(=O)(=O)N(CCOCC(=O)N2CCC(OCCN3CCCC3)(c3ccncc3)CC2)c2ccccc2)c(C)c1

nearest known ligand 0.49

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
BDKRB1 P46663 19/20 0.49
ALDH1A1 P00352 1/20 0.37
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4297398 0.93 BDKRB1 (0.48) BDKRB1
SCHEMBL4303844 0.89 BDKRB1 (0.48) BDKRB1ALDH1A1
SCHEMBL702336 0.88 BDKRB1 (0.51) BDKRB1ALDH1A1GAA
SCHEMBL3441919 0.82 BDKRB1 (0.60) BDKRB1
SCHEMBL703119 0.82 BDKRB1 (0.49) BDKRB1
SCHEMBL3441591 0.82 BDKRB1 (0.59) BDKRB1
SCHEMBL3442052 0.81 BDKRB1 (0.46) BDKRB1
SCHEMBL4298996 0.81 BDKRB1 (0.52) BDKRB1
SCHEMBL3442143 0.81 BDKRB1 (0.48) BDKRB1ALDH1A1
SCHEMBL3441925 0.80 BDKRB1 (0.47) BDKRB1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8318769-B2 Substituted sulfonamide compounds GRUENETHAL GMBH (DE) 2012-11-27 US claimed
US-20090264400-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2009-10-22 US claimed
US-8318769-B2 Substituted sulfonamide compounds GRUENETHAL GMBH (DE) 2012-11-27 US disclosed
US-20090264400-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264400-A1 Substituted Sulfonamide Compounds BDKRB1, BDKRB2, TRPV1 BDKRB1 1/4885ALDH1A1 1956/4885GAA 2852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.